Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Clobetasol propionate ointment can help some people with total hair loss regrow hair.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Free tissue transfer is highly effective for fixing exposed implants after skull surgery.

Low-dose oral minoxidil increases hair thickness and length in children with a hair disorder called Loose Anagen Hair Syndrome.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Fractional resurfacing is safe and effective for certain skin conditions in Asian patients, but care must be taken to avoid skin pigmentation issues.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Blocking certain receptors in the lungs might help treat a specific type of asthma.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Apremilast shows promise for several skin conditions but needs more research.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.